Your browser doesn't support javascript.
loading
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
Nghiem, Paul; Bhatia, Shailender; Lipson, Evan J; Sharfman, William H; Kudchadkar, Ragini R; Brohl, Andrew S; Friedlander, Phillip A; Daud, Adil; Kluger, Harriet M; Reddy, Sunil A; Boulmay, Brian C; Riker, Adam I; Burgess, Melissa A; Hanks, Brent A; Olencki, Thomas; Margolin, Kim; Lundgren, Lisa M; Soni, Abha; Ramchurren, Nirasha; Church, Candice; Park, Song Y; Shinohara, Michi M; Salim, Bob; Taube, Janis M; Bird, Steven R; Ibrahim, Nageatte; Fling, Steven P; Homet Moreno, Blanca; Sharon, Elad; Cheever, Martin A; Topalian, Suzanne L.
Affiliation
  • Nghiem P; 1 University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Bhatia S; 1 University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Lipson EJ; 2 Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD.
  • Sharfman WH; 2 Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD.
  • Kudchadkar RR; 3 Emory University, Atlanta, GA.
  • Brohl AS; 4 Moffitt Cancer Center, Tampa, FL.
  • Friedlander PA; 5 Mount Sinai Medical Center, New York, NY.
  • Daud A; 6 University of California San Francisco, San Francisco, CA.
  • Kluger HM; 7 Yale University, New Haven, CT.
  • Reddy SA; 8 Stanford University, Stanford, CA.
  • Boulmay BC; 9 Louisiana State University, New Orleans, LA.
  • Riker AI; 9 Louisiana State University, New Orleans, LA.
  • Burgess MA; 10 University of Pittsburgh, Pittsburgh, PA.
  • Hanks BA; 11 Duke University Medical Center, Durham, NC.
  • Olencki T; 12 Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Margolin K; 13 City of Hope, Duarte, CA.
  • Lundgren LM; 14 Fred Hutchinson Cancer Research Center/Cancer Immunotherapy Trials Network, Seattle, WA.
  • Soni A; 2 Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD.
  • Ramchurren N; 14 Fred Hutchinson Cancer Research Center/Cancer Immunotherapy Trials Network, Seattle, WA.
  • Church C; 15 University of Washington, Seattle, WA.
  • Park SY; 15 University of Washington, Seattle, WA.
  • Shinohara MM; 15 University of Washington, Seattle, WA.
  • Salim B; 16 Axio Research, Seattle, WA.
  • Taube JM; 2 Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD.
  • Bird SR; 17 Merck Research Laboratories, Kenilworth, NJ.
  • Ibrahim N; 17 Merck Research Laboratories, Kenilworth, NJ.
  • Fling SP; 14 Fred Hutchinson Cancer Research Center/Cancer Immunotherapy Trials Network, Seattle, WA.
  • Homet Moreno B; 17 Merck Research Laboratories, Kenilworth, NJ.
  • Sharon E; 18 National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD.
  • Cheever MA; 14 Fred Hutchinson Cancer Research Center/Cancer Immunotherapy Trials Network, Seattle, WA.
  • Topalian SL; 2 Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD.
J Clin Oncol ; 37(9): 693-702, 2019 03 20.
Article in En | MEDLINE | ID: mdl-30726175
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2019 Document type: Article Country of publication: United States